These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease. Mohandas B; Mehta JL Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545 [TBL] [Abstract][Full Text] [Related]
4. Statins for the primary prevention of cardiovascular disease in women? Birge SJ Menopause; 2012 Dec; 19(12):1287-8. PubMed ID: 23187611 [No Abstract] [Full Text] [Related]
5. [The modern view on the use of aspirin for the primary prophylaxis of cardiovascular diseases in women]. Zakharov OV; Arablinskiĭ AV Klin Med (Mosk); 2006; 84(11):10-5. PubMed ID: 17243603 [TBL] [Abstract][Full Text] [Related]
6. [Development of menopause management and menopausal related hormone replacement therapy]. Yu Q Zhonghua Fu Chan Ke Za Zhi; 2013 Apr; 48(4):287-90. PubMed ID: 23902813 [No Abstract] [Full Text] [Related]
7. Statins and stroke prevention: focus on women. Bushnell CD Ital Heart J; 2004 Aug; 5(8):569-71. PubMed ID: 15554026 [No Abstract] [Full Text] [Related]
8. Hormones and cardiovascular health in women. ESHRE Capri Workshop Group Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276 [TBL] [Abstract][Full Text] [Related]
9. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
10. Aspirin for primary prevention of cardiovascular disease in women: does sex matter? Hung J Med J Aust; 2006 Mar; 184(6):260-1. PubMed ID: 16548826 [TBL] [Abstract][Full Text] [Related]
11. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases. Jochmann N; Stangl K; Garbe E; Baumann G; Stangl V Eur Heart J; 2005 Aug; 26(16):1585-95. PubMed ID: 15996977 [TBL] [Abstract][Full Text] [Related]
12. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health. Gambacciani M; Genazzani AR Gynecol Endocrinol; 2006 Mar; 22(3):115-6. PubMed ID: 16835071 [No Abstract] [Full Text] [Related]
14. Statins in women for primary prevention--is there evidence to back up their use?? Fenton A; Panay N Climacteric; 2010 Oct; 13(5):403-4. PubMed ID: 20738236 [No Abstract] [Full Text] [Related]
15. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI. Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155 [TBL] [Abstract][Full Text] [Related]
16. Statin therapy and the risk for diabetes among adult women: do the benefits outweigh the risk? Ma Y; Culver A; Rossouw J; Olendzki B; Merriam P; Lian B; Ockene I Ther Adv Cardiovasc Dis; 2013 Feb; 7(1):41-4. PubMed ID: 23238515 [TBL] [Abstract][Full Text] [Related]
17. Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users. Lawton B; Rose S; McLeod D; Dowell A BMJ; 2003 Oct; 327(7419):845-6. PubMed ID: 14551101 [No Abstract] [Full Text] [Related]
18. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease. Hennekens CH; Schneider WR Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910 [TBL] [Abstract][Full Text] [Related]
19. High sensitivity C-reactive protein in cardiovascular risk assessment. CRP mania or useful screening? Sellmayer A; Limmert T; Hoffmann U Int Angiol; 2003 Mar; 22(1):15-23. PubMed ID: 12771851 [TBL] [Abstract][Full Text] [Related]